XW LABORATORIES
XW Laboratories is an Asia-Pacific biopharmaceutical company dedicated to discovering and developing transformational medicines that will markedly improve the quality of life in patients suffering from neurological disorders. Founded in 2014, XW Laboratories has developed 3 unique drug R&D platforms that not only allow us to improve upon existing medication through approaches such as prodrug and functional group switch, but also be at the forefront of medicinal technology in immunoneurology through the application of their mitochondria-targeting platform.
XW LABORATORIES
Social Links:
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2014-01-01
Address:
Wuhan, Hubei, China
Country:
China
Website Url:
http://www.xwpharma.com
Total Employee:
11+
Status:
Active
Contact:
+862787635677
Email Addresses:
[email protected]
Total Funding:
57.5 M USD
Technology used in webpage:
SPF Microsoft Exchange Online Amazon Office 365 Mail Microsoft Azure DNS AWS Global Accelerator HiChina DNS
Similar Organizations
1200 Pharma
1200 Pharma is a medicinal chemistry technology company that accelerates pre-clinical drug discovery and clinical approval timelines.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
FORMA Therapeutics
FORMA Therapeutics is a biopharmaceutical company focused on the discovery, development, and commercialization of transformative medicines.
Current Employees Featured
Founder
Investors List
Orient Hontai Capital
Orient Hontai Capital investment in Series C - XW Laboratories
WuXi Healthcare Ventures
WuXi Healthcare Ventures investment in Series C - XW Laboratories
KTB Network
KTB Network investment in Series C - XW Laboratories
Johnson & Johnson Innovation
Johnson & Johnson Innovation investment in Series C - XW Laboratories
CDIB Capital
CDIB Capital investment in Series C - XW Laboratories
Trinity Innovation Fund
Trinity Innovation Fund investment in Series C - XW Laboratories
Panacea Venture
Panacea Venture investment in Series C - XW Laboratories
Element Capital Management LLC
Element Capital Management LLC investment in Series B - XW Laboratories
WuXi Healthcare Ventures
WuXi Healthcare Ventures investment in Series B - XW Laboratories
WI Harper Group
WI Harper Group investment in Series B - XW Laboratories
Official Site Inspections
http://www.xwpharma.com Semrush global rank: 5.78 M Semrush visits lastest month: 1.44 K
- Host name: a20b9ee60132ef283.awsglobalaccelerator.com
- IP address: 13.248.155.104
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
More informations about "XW Laboratories"
XWPharma - Crunchbase Company Profile & Funding
XWPharma is a neuroscience biotech company that is researching new medicines for sleep, neuropsychiatric, and other neglected CNS illnesses. …See details»
XWPharma - LinkedIn
XWPharma | 1,089 followers on LinkedIn. Neuroscience biotech developing novel therapeutics for sleep, neuropsych, and other underserved CNS disorders. | We are a global biotech with a pipeline of ...See details»
XWPharma 2025 Company Profile: Valuation, Funding …
Who are XWPharma’s competitors? Harmony Biosciences, Cassava Sciences, Iconic Therapeutics, NeuroNascent, and T3D Therapeutics are some of the 77 …See details»
XWPharma Company Profile | Management and Employees List
XWPharma Profile and History XWPharma is a biopharmaceutical company dedicated to the discovery and development of novel therapeutics, utilizing its proprietary platform chemistry. …See details»
XWPharma Company Profile - Office Locations, Competitors
XWPharma has 5 employees across 2 locations and $57.5 m in total funding,. See insights on XWPharma including office locations, competitors, revenue, financials, executives, …See details»
XWPharma Incorporated Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for XWPharma Incorporated of Redwood City, CA. Get the latest business insights from Dun & Bradstreet.See details»
XWPharma - Funding, Financials, Valuation & Investors - Crunchbase
XWPharma is a neuroscience biotech company that is researching new medicines for sleep, neuropsychiatric, and other neglected CNS illnesses. New. Resources. ... How much funding …See details»
XWPharma - 2025 Company Profile, Funding & Competitors - Tracxn
Mar 22, 2025 XWPharma Initiates First-in-Human Studies of XW10508, in Development for Fast-acting Relief of Treatment-Resistant Depression and Chronic Painpipelinereview.com • Sep …See details»
XWPharma - Contacts, Employees, Board Members, Advisors
XWPharma is a neuroscience biotech company that is researching new medicines for sleep, neuropsychiatric, and other neglected CNS illnesses. ... Log In. Log In. Experience the new …See details»
XWPharma - VentureRadar
We are a clinical stage biopharmaceutical company dedicated to the discovery and development of therapeutics applying novel platform chemistry to... ... Find out more ...See details»
XWPharma Announces $40 Million Financing and Appoints …
REDWOOD CITY, Calif. and WUHAN, China, Sept. 17, 2020 (GLOBE NEWSWIRE) -- XWPharma (formerly XW Laboratories), a biopharmaceutical company dedicated to the …See details»
XWPharma Ltd. - Drug pipelines, Patents, Clinical trials - Synapse
Mar 20, 2025 Explore XWPharma Ltd. with its drug pipeline, therapeutic area, technology platform, 3 clinical trials, Disease Domain:Nervous System Diseases, Technology …See details»
XWPharma Announces $40 Million Financing and Appoints
Sep 17, 2020 Company Builds its Development and Commercial Organization to Expand its Global Business Operations . REDWOOD CITY, Calif. and WUHAN, China, Sept. 17, 2020 …See details»
XWPharma Announces $40 Million Financing and Appoints …
Sep 17, 2020 Additional Capital Enables Advancement of Novel, Internally-Discovered Neuroscience Programs in Clinical Development Company Builds its Development and …See details»
XWPharma Initiates First-in-Human Studies of XW10508, in …
REDWOOD CITY, Calif. and WUHAN, China, Sept. 08, 2021 (GLOBE NEWSWIRE) -- XWPharma Ltd. today announced dosing of subjects in its first-in-human study evaluating …See details»
XW Laboratories - Crunchbase Company Profile & Funding
XW Laboratories is an Asia-Pacific biopharmaceutical company dedicated to discovering and developing transformational medicines that will markedly improve the quality of life in patients …See details»
XWPharma Announces $40 Million Financing and ... - Associated …
Additional Capital Enables Advancement of Novel, Internally-Discovered Neuroscience Programs in Clinical Development Company Builds its Development and Commercial Organization to …See details»
XWPharma Names Glen Giovannetti to Board of Directors
REDWOOD CITY, Calif. and WUHAN, China, Feb 25, 2021 (GLOBE NEWSWIRE) – XWPharma Ltd. today announced that Glen Giovannetti has been appointed to the company’s Board of …See details»
WI Harper Group-backed XWPharma Raises $40 Million Series C …
Sep 18, 2020 XWPharma (formerly XW Laboratories) is a biopharmaceutical company dedicated to the discovery and development of therapeutics that apply platform chemistry to …See details»